Atherosclerosis
Volume 192, Issue 2 , Pages 259-265 , June 2007

Paradoxical increase in LDL oxidation by endothelial cells from an atherosclerosis-resistant mouse strain

  • Toru Miyoshi

      Affiliations

    • Department of Radiology, University of Virginia, Charlottesville, VA 22908, United States
    • Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908, United States
    • ,
  • Alan H. Matsumoto

      Affiliations

    • Department of Radiology, University of Virginia, Charlottesville, VA 22908, United States
    • ,
  • Weibin Shi

      Affiliations

    • Department of Radiology, University of Virginia, Charlottesville, VA 22908, United States
    • Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908, United States
    • Corresponding Author InformationCorresponding author at: University of Virginia, P.O. Box 801339, MR4 Bldg, Room 1171, 409 Lane Road, Charlottesville, VA 22908, United States. Tel.: +1 434 243 9420; fax: +1 434 982 5680.

Received 3 April 2006 ,Revised 10 June 2006 ,Accepted 11 July 2006.

References 

  1. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med. 2002;8:1211–1217
  2. Cushing SD, Berliner JA, Valente AJ, et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA. 1990;87:5134–5138
  3. Rajavashisth TB, Andalibi A, Territo MC, et al. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 1990;344:254–257
  4. Kume N, Cybulsky MI, Gimbrone MA. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 1992;90:1138–1144
  5. Khan BV, Parthasarathy SS, Alexander RW, et al. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest. 1995;95:1262–1270
  6. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA. 1988;85:9748–9752
  7. Van Berkel TJ, Kruijt JK, De Smidt PC, et al. Receptor-dependent targeting of lipoproteins to specific cell types of the liver. Targeted Diagn Ther. 1991;5:225–249
  8. Brown MD, Jin L, Jien ML, et al. Lipid retention in the arterial wall of two mouse strains with different atherosclerosis susceptibility. J Lipid Res. 2004;45:1155–1161
  9. Miyoshi T, Tian J, Matsumoto AH, et al. Differential response of vascular smooth muscle cells to oxidized LDL in mouse strains with different atherosclerosis susceptibility. Atherosclerosis. 2006;
  10. Morel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 1984;4:357–364
  11. Steinbrecher UP, Parthasarathy S, Leake DS, et al. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA. 1984;81:3883–3887
  12. Folcik VA, Nivar-Aristy RA, Krajewski LP, et al. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J Clin Invest. 1995;96:504–510
  13. Kuhn H, Belkner J, Zaiss S, et al. Involvement of 15-lipoxygenase in early stages of atherogenesis. J Exp Med. 1994;179:1903–1911
  14. Heinecke JW. Pathways for oxidation of low density lipoprotein by myeloperoxidase: tyrosyl radical, reactive aldehydes, hypochlorous acid and molecular chlorine. Biofactors. 1997;6:145–155
  15. Fang X, Weintraub NL, Rios CD, et al. Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells. Circ Res. 1998;82:1289–1297
  16. Meilhac O, Zhou M, Santanam N, et al. Lipid peroxides induce expression of catalase in cultured vascular cells. J Lipid Res. 2000;41:1205–1213
  17. Shi W, Wang X, Shih DM, et al. Paradoxical reduction of fatty streak formation in mice lacking endothelial nitric oxide synthase. Circulation. 2002;105:2078–2082
  18. Xia Y, Tsai AL, Berka V, et al. Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem. 1998;273:25804–25808
  19. Huie RE, Padmaja S. The reaction of no with superoxide. Free Radic Res Commun. 1993;18:195–199
  20. Paigen B, Mitchell D, Holmes PA, et al. Genetic analysis of strains C57BL/6J and BALB/cJ for Ath-1, a gene determining atherosclerosis susceptibility in mice. Biochem Genet. 1987;25:881–892
  21. Tian J, Pei H, James JC, et al. Circulating adhesion molecules in apoE-deficient mouse strains with different atherosclerosis susceptibility. Biochem Biophys Res Commun. 2005;329:1102–1107
  22. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345–1353
  23. Watson AD, Leitinger N, Navab M, et al. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem. 1997;272:13597–13607
  24. Shi W, Haberland ME, Jien ML, et al. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation. 2000;102:75–81
  25. Morel DW, Chisolm GM. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res. 1989;30:1827–1834
  26. Funk CD, Cyrus T. 12/15-lipoxygenase, oxidative modification of LDL and atherogenesis. Trends Cardiovasc Med. 2001;11:116–124
  27. Kuhn H, Belkner J, Suzuki H, et al. Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities. J Lipid Res. 1994;35:1749–1759
  28. Rankin SM, Parthasarathy S, Steinberg D. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J Lipid Res. 1991;32:449–456
  29. Shi W, Wang NJ, Shih DM, et al. Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circ Res. 2000;86:1078–1084

PII: S0021-9150(06)00413-8

doi: 10.1016/j.atherosclerosis.2006.07.016

Atherosclerosis
Volume 192, Issue 2 , Pages 259-265 , June 2007

Article Tools

* Image Usage & Resolution